查詢結果分析
相關文獻
- Elevation of Intraocular Pressure after Intravitreal Injection of Triamcinolone Acetonide in Taiwanese Patients
- The Effects on Intraocular Pressure with Intravitreal Injection of Cyclodestructive Gentamicin in Dogs with Persistent Glaucoma
- Acute Intraocular Pressure Elevation Attack Following a 2.5mg Dosage of Intravitreal Injection of Bevacizumag (Avastin): A Case Report
- New Diagnostic Techniques of Canine Glaucoma: The Use of Slit-Lamp Biomicroscopy, Electronic Applanation Tonometry, and Gonioscopy in Glaucoma-Affected Dogs
- Hormonal Changes Associated with Menstrual Cycle Have no Definite Influence on Ocular Pressure
- Monthly Measurements of Intraocular Pressure in Normal, Ocular Hypertensive, and Glaucoma Male Subjects of Same Age Group
- 第二代無接觸平壓式眼壓計與Goldmann氏平壓式眼壓計的眼內壓測量比較
- 犬貓青光眼的病因、診斷、治療與保健
- Refractory Macular Edema Treated by Intravitreal Adalimumab in a Patient with Central Retinal Vein Occlusion
- Intravitreal Triamcinolone for Purtscher's Retinopathy--A Case Report
頁籤選單縮合
題名 | Elevation of Intraocular Pressure after Intravitreal Injection of Triamcinolone Acetonide in Taiwanese Patients=臺灣人接受玻璃體內注射康寧克通A之後的眼壓上升情形 |
---|---|
作者 | 張祐誠; 吳文權; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷期 | 24:2 2008.02[民97.02] |
頁次 | 頁72-77 |
分類號 | 416.745 |
關鍵詞 | 類固醇引起之青光眼; 眼內壓; 玻璃體內注射; 康寧克通A; Corticosteroid-induced glaucoma; Intraocular pressure; Intravitreal injection; Triamcinolone acetonide; |
語文 | 英文(English) |
中文摘要 | 本篇研究目的在探討病人接受玻璃體內注射康寧克通 A 之後發生眼壓上升的比例以及時間點。回顧性的探討包括 52 位病人,所有的病人都接受單次玻璃體內注射 4 毫克的康寧克通 A。有意義的眼壓上升定義為術後的眼壓高於 21 毫米汞柱。本研究包含了 26 位男性以及 26 位女性。平均年齡為 59.4 歲,術前的平均眼壓以及術後的平均最高眼壓分別為 14.6 毫米汞柱以及 21.5 毫米汞柱。當中有 19 位病人 (36.5%) 在術後平均 26 天後發生了有意義的眼壓上升。而 19 位病人當中有 17 位的眼壓可以用局部青光眼藥物得到有效的控制。不論術後是否發生了有意義的眼壓上升,在玻璃體內注射 4 毫克的康寧克通 A 術後發生眼壓上升的情形是很常見的,這個現象通常發生在術後一個月左右。因此對於考慮接受這項治療的病人應該充分被告知這項副作用。 |
英文摘要 | The purpose of this study was to investigate the incidence and timing of elevation in intraocular pressure (IOP) after intravitreal injection of triamcinolone acetonide (IVTA). This was a retrospective observational case series that included 52 eyes from 52 patients. All patients received intravitreal injection with 4 mg of triamcinolone acetonide. Significant IOP elevation was defined as pressure greater than 21 mmHg. There were 26 males and 26 females included in this study. The mean age was 59.4 years. The mean IOP at baseline and postoperative mean highest IOP were 14.6 mmHg and 21.5 mmHg, respectively. There were 19 (36.5%) patients who experienced significant IOP elevation at a mean of 26.0 days after IVTA. IOP was well-controlled by topical antiglaucoma medication in 17 of these 19 patients. IOP elevation after intravitreal injection with 4 mg of triamcinolone acetonide is not a rare finding. This phenomenon usually starts approximately 1 month after IVTA. Patients considering this treatment should be fully informed of this known adverse effect. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。